NKGen Biotech, Inc. (NKGN)
OTCMKTS · Delayed Price · Currency is USD
0.0021
0.00 (0.00%)
At close: Sep 17, 2026
NKGen Biotech Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -23.55 | -44.29 | -82.95 | -26.75 | -23.27 |
Depreciation & Amortization | 1.37 | 1.32 | 1.2 | 1.21 | 1.24 |
Loss (Gain) From Sale of Assets | 0 | 0.01 | - | - | - |
Stock-Based Compensation | 3.73 | 4.14 | 4.14 | 0.07 | 0.09 |
Other Operating Activities | -1.18 | 16.57 | 53.44 | 2.89 | 1.45 |
Change in Accounts Receivable | - | - | 0.03 | -0.03 | 0.11 |
Change in Accounts Payable | 1.49 | 2.26 | 3.99 | 0.44 | 0.96 |
Change in Other Net Operating Assets | -1.5 | -0.89 | -1.8 | -0.38 | -0.14 |
Operating Cash Flow | -19.65 | -20.88 | -21.95 | -22.56 | -19.55 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | - | - | - | -0.1 | -0.4 |
Sale of Property, Plant & Equipment | - | 0.04 | - | - | - |
Sale (Purchase) of Intangibles | -0.1 | -0.05 | -0.05 | -0.06 | -0.06 |
Investing Cash Flow | -0.1 | -0.01 | -0.05 | -0.16 | -0.46 |
Financing Activities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | - | 1.18 | 10.29 | 23 | 20.5 |
Long-Term Debt Issued | - | 16.19 | 16.22 | - | - |
Total Debt Issued | 17.78 | 17.37 | 26.51 | 23 | 20.5 |
Short-Term Debt Repaid | - | -1.84 | -0.3 | -0.68 | -0.4 |
Long-Term Debt Repaid | - | -1.17 | - | - | - |
Total Debt Repaid | -4.01 | -3.01 | -0.3 | -0.68 | -0.4 |
Net Debt Issued (Repaid) | 13.77 | 14.35 | 26.21 | 22.33 | 20.1 |
Issuance of Common Stock | 5.21 | 3.46 | 1.68 | 0.16 | 0.06 |
Other Financing Activities | 0.51 | 3.04 | -5.73 | - | - |
Financing Cash Flow | 19.49 | 20.85 | 22.16 | 22.49 | 20.16 |
Net Cash Flow
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | -0.26 | -0.04 | 0.16 | -0.23 | 0.15 |
Free Cash Flow
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -19.65 | -20.88 | -21.95 | -22.66 | -19.95 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | - | - | - | -29425.97% | -4683.33% |
Free Cash Flow Per Share | -0.56 | -0.72 | -1.42 | -3.56 | -1.40 |
Levered Free Cash Flow | -20.95 | -26.91 | 11.32 | -16.94 | - |
Unlevered Free Cash Flow | -19.59 | -25.2 | 11.78 | -15.5 | - |
Additional Metrics
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Change in Working Capital | -0.02 | 1.37 | 2.23 | 0.03 | 0.93 |